Bayer Cropscience Limited
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more
Market Cap & Net Worth: Bayer Cropscience Limited (BAYERCROP)
Bayer Cropscience Limited (NSE:BAYERCROP) has a market capitalization of $2.33 Billion (₹201.68 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #7388 globally and #277 in its home market, demonstrating a -0.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bayer Cropscience Limited's stock price ₹4487.60 by its total outstanding shares 44942092 (44.94 Million).
Bayer Cropscience Limited Market Cap History: 2015 to 2026
Bayer Cropscience Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.56 Billion to $2.33 Billion (3.07% CAGR).
Index Memberships
Bayer Cropscience Limited is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$1.27 Trillion | 0.08% | #251 of 500 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$342.58 Billion | 0.29% | #119 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.73 Billion | 0.18% | #166 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.07% | #251 of 750 |
Weight: Bayer Cropscience Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bayer Cropscience Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bayer Cropscience Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Bayer Cropscience Limited's market cap is 0.04 times its annual revenue
0.23x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.42x
Bayer Cropscience Limited's market cap is 0.42 times its annual earnings
5.23x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.92 Billion | $27.84 Billion | $3.15 Billion | 0.07x | 0.61x |
| 2017 | $2.04 Billion | $28.15 Billion | $2.91 Billion | 0.07x | 0.70x |
| 2018 | $1.93 Billion | $27.17 Billion | $3.00 Billion | 0.07x | 0.64x |
| 2019 | $1.64 Billion | $31.75 Billion | $3.37 Billion | 0.05x | 0.49x |
| 2020 | $2.55 Billion | $36.09 Billion | $4.75 Billion | 0.07x | 0.54x |
| 2021 | $2.40 Billion | $42.61 Billion | $4.93 Billion | 0.06x | 0.49x |
| 2022 | $2.45 Billion | $47.34 Billion | $6.45 Billion | 0.05x | 0.38x |
| 2023 | $2.82 Billion | $51.40 Billion | $7.58 Billion | 0.05x | 0.37x |
| 2024 | $2.88 Billion | $51.06 Billion | $7.41 Billion | 0.06x | 0.39x |
| 2025 | $2.37 Billion | $54.73 Billion | $5.68 Billion | 0.04x | 0.42x |
Competitor Companies of BAYERCROP by Market Capitalization
Companies near Bayer Cropscience Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Bayer Cropscience Limited by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Bayer Cropscience Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Bayer Cropscience Limited's market cap moved from $1.56 Billion to $ 2.33 Billion, with a yearly change of 3.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹2.33 Billion | -1.54% |
| 2025 | ₹2.37 Billion | -17.89% |
| 2024 | ₹2.88 Billion | +2.07% |
| 2023 | ₹2.82 Billion | +15.36% |
| 2022 | ₹2.45 Billion | +2.10% |
| 2021 | ₹2.40 Billion | -5.96% |
| 2020 | ₹2.55 Billion | +55.81% |
| 2019 | ₹1.64 Billion | -15.11% |
| 2018 | ₹1.93 Billion | -5.53% |
| 2017 | ₹2.04 Billion | +6.30% |
| 2016 | ₹1.92 Billion | +23.28% |
| 2015 | ₹1.56 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bayer Cropscience Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.33 Billion USD |
| MoneyControl | $2.33 Billion USD |
| MarketWatch | $2.33 Billion USD |
| marketcap.company | $2.33 Billion USD |
| Reuters | $2.33 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.